基于网络药理学探讨槲皮素靶向NOX4抗非小细胞肺癌的作用机制OA
Exploring the Mechanism of Quercetin Targeting NOX4 Against Non-Small Cell Lung Cancer Based on Network Pharma-cology
[目的]基于网络药理学探讨槲皮素(Quercetin)抗非小细胞肺癌(non-small cell lung cancer,NSCLC)的潜在作用靶点,并验证其对NSCLC细胞增殖、迁移及侵袭的影响.[方法]采用Swiss Target Prediction及相似性集合方法(Similarity Ensemble Approach,SEA)数据库筛选槲皮素的潜在作用靶点,并从人类基因综合数据库(The Human Gene Database,GeneCards)中获取NSCLC相关疾病靶点.结合基因表达综合(Gene Expression Omnibus,GEO)数据库肺癌及癌旁组织转录组数据,确定槲皮素与NSCLC的共同靶点,并绘制维恩图.利用Metascape及SangerBox平台进行基因本体(gene ontology,GO)与京都基因与基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)通路富集分析.通过AutoDock Vina 1.5.7软件进行分子对接,并以分子动力学模拟评估槲皮素与靶蛋白的结合稳定性.采用肿瘤免疫评估资源(Tumor Immune Estimation Resource,TIMER)与基因表达谱交互分析2(Gene Expression Profiling Interactive Analysis 2,GEPIA2)数据库,分析关键靶蛋白在肺癌患者中的表达特征及预后相关性.以免疫印迹及免疫荧光检测槲皮素对靶蛋白及目标信号通路的影响,细胞增殖计数及克隆形成实验检测其对NSCLC细胞增殖的抑制作用,划痕与Transwell实验评估细胞迁移和侵袭能力.[结果]网络药理学与生物信息学分析表明,槲皮素与肺癌相关的共同潜在靶点共有26个.Swiss Target Prediction数据库分析结果显示,NADPH氧化酶4(NADPH oxidase 4,NOX4)是槲皮素的首位可能潜在靶点.KEGG及GO富集分析结果显示,槲皮素可能通过磷脂酰肌醇3-激酶-蛋白激酶B(phosphatidylinositol 3-kinase-protein kinase B,PI3K-AKT)信号通路调控NSCLC.分子对接与分子动力学模拟结果证实,槲皮素可稳定结合于NOX4蛋白.免疫印迹及生物信息学分析表明,NOX4在NSCLC患者肺癌组织中高表达,且与NSCLC患者不良预后显著相关.细胞实验证实,槲皮素能够显著下调H1975及PC9细胞中NOX4蛋白表达.与对照组比较,槲皮素低、高剂量组还能显著抑制PI3K-AKT信号通路关键蛋白PI3K及AKT的磷酸化水平,并降低细胞的增殖、迁移和侵袭能力.[结论]槲皮素可靶向下调NOX4表达,并抑制PI3K-AKT信号通路的激活,从而阻断NSCLC细胞的恶性生物学行为.
[Objective]To explore the potential targets of quercetin against non-small cell lung cancer(NSCLC)based on network pharmacology,and to validate its effects on the proliferation,migration and invasion of NSCLC cells.[Methods]The Swiss Target Prediction and Similarity Ensemble Approach(SEA)databases were used to screen potential targets of quercetin.The NSCLC-related targets were obtained from The Human Gene Database(GeneCards).Transcriptomic data of lung cancer and adjacent tissues from the Gene Expression Omnibus(GEO)database were integrated to identify common targets between quercetin and NSCLC,and construct Venn diagram.The enrichment analyses,including gene ontology(GO)and Kyoto encyclopedia of genes and genomes(KEGG)pathway analyses,were performed by using the Metascape and SangerBox platforms.Molecular docking was conducted by using AutoDock Vina 1.5.7 software,and molecular dynamics(MD)simulations were employed to assess the binding stability of quercetin with the target protein.The Tumor Immune Estimation Resource(TIMER)and Gene Expression Profiling Interactive Analysis 2(GEPIA2)databases were utilized to analyze the expression characteristics and prognostic relevance of key target proteins in lung cancer patients.Western blot and immunofluorescence were used to detect the effects of quercetin on target protein expression and the relevant signaling pathway.Cell counting kit-8(CCK-8)and colony formation assays were performed to evaluate the effect of quercetin on NSCLC cell proliferation,while scratch wound healing and Transwell assays were used to assess cell migration and invasion capabilities.[Results]Network pharmacology and bioinformatics analyses revealed 26 common potential targets associated with quercetin and lung cancer.Swiss Target Prediction database analysis indicated that NADPH oxidase 4(NOX4)was the most likely potential target of quercetin.The KEGG and GO enrichment analyses suggested that quercetin may regulate NSCLC through phosphatidylinositol 3-kinase-protein kinase B(PI3K-AKT)signaling pathway.Molecular docking and molecular dynamics simulations confirmed that quercetin stably binded to the NOX4 protein.Western blot demonstrated that NOX4 was highly expressed in lung cancer tissues and was significantly associated with poor prognosis in NSCLC patients,along with bioinformatic analysis.Cellular experiments further demonstrated that quercetin significantly downregulated NOX4 protein expression in H1975 and PC9 cells.Compared with control group,both low and high-dose quercetin treatments significantly inhibited the phosphorylation levels of key proteins PI3K and AKT in PI3K-AKT signaling pathway and effectively reduced cell proliferation,migration and invasion.[Conclusion]Quercetin suppresses the malignant biological behaviors of NSCLC cells by targeted downregulating NOX4 expression and inhibiting the activation of PI3K-AKT signaling pathway.
魏友煜;姚奏英;戴梦圆;纪建松;官碧华;王一帆;翁巧优;杨阳;吴兵;方世记;郑丽云;贾丽秋
浙江中医药大学丽水联合培养基地 浙江,丽水 323000||温州医科大学附属第五医院浙江中医药大学丽水联合培养基地 浙江,丽水 323000||温州医科大学附属第五医院浙江中医药大学丽水联合培养基地 浙江,丽水 323000||温州医科大学附属第五医院浙江中医药大学丽水联合培养基地 浙江,丽水 323000||温州医科大学附属第五医院温州医科大学附属第五医院温州医科大学附属第五医院浙江中医药大学丽水联合培养基地 浙江,丽水 323000||温州医科大学附属第五医院浙江中医药大学丽水联合培养基地 浙江,丽水 323000||温州医科大学附属第五医院浙江中医药大学丽水联合培养基地 浙江,丽水 323000||温州医科大学附属第五医院浙江中医药大学丽水联合培养基地 浙江,丽水 323000||温州医科大学附属第五医院浙江中医药大学丽水联合培养基地 浙江,丽水 323000||温州医科大学附属第五医院浙江中医药大学丽水联合培养基地 浙江,丽水 323000||温州医科大学附属第五医院
医药卫生
槲皮素非小细胞肺癌NOX4网络药理学PI3K-AKT信号通路分子动力学模拟
quercetinNSCLCNOX4network pharmacologyPI3K-AKT signaling pathwaymolecular dynamics simulation
《浙江中医药大学学报》 2026 (5)
530-540,549,12
浙江省医药卫生科技计划项目(2025KY1958)浙江省自然科学基金重点项目(LLSSZ25H280002)浙江省中医药管理局重点项目(GZY-KJS-ZJ-2025-065) Zhejiang Medical and Health Science and Technology Plan Project(2025KY1958)Key Project of Zhejiang Provincial Natural Science Foundation(LLSSZ25H280002)Key Project of Zhejiang Provincial Administration of Traditional Chinese Medicine(GZY-KJS-ZJ-2025-065)
评论